|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Cash flows from operating activities | |||||
| Net loss from continuing operations, net of income taxes | |||||
| Net income (loss) from discontinued operations, net of income taxes | |||||
| Adjustments required to reconcile net (loss) income to net cash provided by (used in) operating activities: | |||||
| Impairment charges | |||||
| Depreciation and amortization expense | |||||
| Gain on sale of discontinued operations, before income taxes | |||||
| Loss from sublease | |||||
| Amortization of acquired technology | |||||
| Bad debt expense | |||||
| Deferred tax benefit | |||||
| Amortization of operating lease right-of-use-asset | |||||
| Mark-to-market expense | |||||
| Compensation expense related to the acquisition-contingent consideration | |||||
| Deferred tax expense (benefit) | |||||
| Loss on disposal of property and equipment | |||||
| Stock based compensation expense | |||||
| Stock-based long-term incentive compensation expense | |||||
| Net change in operating assets and liabilities: | |||||
| Increase in accounts receivable | |||||
| Decrease in contingent consideration on acquisition | |||||
| Increase in prepaid expenses, other current assets and other long-term assets | |||||
| Increase in accounts payable and accrued expenses | |||||
| Increase (decrease) in other current liabilities | |||||
| Decrease in deferred tax liability | |||||
| Decrease in operating lease liability | |||||
| Increase (decrease) in deferred rent and security deposits payable | |||||
| Decrease/(increase) in restricted cash | |||||
| (Decrease) increase in deferred income | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash provided by (used in) in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Purchase of patents not subject to amortization | |||||
| Acquisition, net of cash acquired | |||||
| Cash received from sale of discontinued operations | |||||
| Expenses paid with respect to sale of discontinued operations | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Payment of contingent consideration on acquisition | |||||
| Proceeds from the exercise of stock option awards | |||||
| Principal portion of capital lease payments | |||||
| Treasury stock — repurchase of stock | |||||
| Tax withholdings related to net share settlements of restricted stock units | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Effect of exchange rate changes in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Cash, cash equivalents at beginning of year | |||||
| Cash, cash equivalents at end of year | |||||
Loading...